Community/Retail

Syringe services programs (SSPs) aim to reduce the spread of HIV among people who inject drugs (PWID), as use of shared needles puts them at high risk of contracting or transmitting the infection.

Persistent vaccine-induced immunity through the typical cold weather, high risk period, and into the subsequent seasons is important in areas with year-round influenza activity.

Several recent studies, blogs and articles have raised a question in my mind about how secure independant pharmacy practice is.

An antiretroviral vaginal ring is being investigated to quell the spread of HIV.

Boehringer Ingelheim has announced that the FDA has granted orphan drug designation to nintedanib, a triple angiokinase inhibitor, for the treatment of mesothelioma.

Officials with Elite Pharmaceuticals have filed an abbreviated new drug application with the FDA for a generic version of Norco (hydrocodone bitartrate and acetaminophen tablets) in doses of 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg.

Manufacturers care about their pipeline of medications. Why do pharmacies?

Officials with the FDA have expanded the use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose testing for diabetes treatment decisions in people 2 years of age and older with diabetes,

The Generic Pharmaceutical Association (GPhA) shares President Elect Donald J. Trump and the incoming Administration’s commitment to lowering drug costs.

Gallup has released the results of its annual survey about which professions Americans deem the most honest and maintain the highest ethical standards. Once again pharmacists are highly rated, finishing second on the list.

This legislation has introduced several new requirements for pharmacies, and many pharmacists are wondering what steps can be taken to implement the requirements contained within.

A sharp rise in opioid-related complications among newborns in rural communities highlights the severity of the opioid epidemic in these areas.

The CVS Health Charity Classic has reached an important milestone a total of $20 million dollars in philanthropic support to hundreds of nonprofits in Southeastern New England since the event series' inception in 1999.

Walgreens Boots Alliance and Rite Aid Corporation have announced that they have entered into an agreement to sell 865 Rite Aid stores and certain assets related to store operations to Fred's, Inc. for $950 million in an all-cash transaction.

Avella has announced that it has been selected by Clovis Oncology to distribute Rubraca, an oral therapy for ovarian cancer.

The FDA has granted orphan drug designation to AbbVie for risankizumab (ABBV-066) for the treatment of Crohn’s disease in pediatric patients.

As the year comes to an end, pharmacy students may be looking forward to a much needed semester break.

It’s that time of the year again where we all feed our faces and start to dread stepping back on the scale. You want to lose the weight but you just can’t stop eating. You keep telling yourself you will start your diet Monday or after the holidays. Not only is all of the food you’re ingesting adding numbers to the scale, but it’s also putting you at an increased risk of developing diseases such as congestive heart disease, hypertension, stroke, type 2 diabetes, and various cancers. Here is some information that may help you keep the weight off and start shedding some pounds.

Novo Nordisk submitted the supplemental New Drug Application (sNDA) based on the results of the BEGIN Young 1 trial, a multi-national, 26-week, phase 3b, randomized, controlled, clinical trial.

Officials with Mylan have announced the launch of generic EpiPen (epinephrine injection, USP) Auto-Injector at half the cost of its brand name counterpart.

In a letter to the new power structure in Washington, D.C., the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA), the American Pharmacists Association (APhA), and the National Alliance of State Pharmacy Associations (NASPA) have detailed steps necessary to leverage pharmacy patient care and prevent higher costs that result from untreated conditions.

Officials with Clovis Oncology announced today they have received accelerated FDA approval for Rubraca (rucaparib) to treat advanced ovarian cancers in women.

Approximately 1.2 million individuals live with HIV/AIDS in the United States. This population is at an increased risk of opportunistic infections (OIs), an area where pharmacists have significant potential to make meaningful interventions.

Healthy People 2020, the national health promotion and disease intervention initiative, set the goal influenza vaccination rate in the community at 70%. Despite this goal, reports show that vaccination rates are way under expectations at 44%.

Removal of the boxed warning is based on the outcomes of EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study), which is a randomized, blinded, active- and placebo-controlled clinical trial, in patients without and with a history of psychiatric disorder.

Managing cancer pain is a challenge for patients and providers alike.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.